* Updated program and speaker information. (Wednesday, April 8)
This event serves as a platform for in-depth industrial and technical exchange between Taiwan and Japan, fostering opportunities for resource integration, strategic partnerships, and business collaboration.
The program will feature three thematic presentations covering investment in the biotechnology industry and developments in regenerative medicine. In addition, multiple Taiwanese and Japanese companies will share their research and technologies through company pitch sessions.
By strengthening bilateral cooperation in the biotechnology and pharmaceutical sectors, the event aims to promote industrial development, technological innovation, and international market expansion.
Language:English (Simultaneous Translation NOT available)
Date: Wednesday, April 22, 14:30-18:00
Nihonbashi Life Science HUB
(8F Muromachi Chibagin Mitsui Building 1-5-5, Nihonbashi-muromachi, Chuo-ku, Tokyo)
(Opens an external site)
Program
| Time | Agenda |
| 14:00 - 14:30 | Registration |
| 14:30 - 14:33 | Welcome Address Dr. Michael Huang / Director of BPIPO |
| 14:33 - 14:45 | Opening Remarks Dr. Shiing-Jer Twu / Chairman of DCB Dr. Ikuo Hayashi / President and Chief Operating Officer of Link-J Mr. Kunihiko Suzuki / Chair, Specific Proceeded Cells Committee of FIRM |
| 14:45 - 14:50 | Group Photo Session |
| 14:50 - 15:00 | Investment Landscapes in Taiwan and Japan Shuntaro Kodama / Managing Director of DCI Partners |
| 15:00 - 15:15 | Introduction of Companies –Taiwan Hualien Tzu Chi Hospital / HERON NEUTRON MEDICAL CORP. |
| 15:15 - 15:35 | Introduction of Companies – Japan SyntheticGestalt K.K. / DiveRadGel Co., Ltd. / Auxilart Co., Ltd. / Amelieff Coporation / FonesLife Coporation |
| 15:35 - 15:55 | Break Time |
| 15:55 - 16:05 | Current status of Regenerative Medicine in Taiwan: Regulatory and Industry Perspectives Dr. Wannhsin Chen / President of TACT (Taiwan Association for Cellular Therapy) Vice president of Hexun Biosciences Co. |
| 16:05 - 16:30 | Introduction of Companies –Taiwan AngenMed Therapeutics, Inc. / STEMCELL BioTech CO., LTD. / HeXun Biosciences Co., Ltd. / TIMING PHARMACEUTICAL CO., LTD. / Taiwan Exosome CO., LTD. / Spirit Scientific Co., Ltd / Steminent Biotherapeutics Inc. |
| 16:30-16:40 | Current Regenerative Medicine Landscape in Japan: Regulations and Market Status Dr. Takashi Yamamoto / Chair, International Affairs Committee and CDMO Sub-committee of FIRM |
| 16:40-17:00 | Introduction of Companies – Japan Cellafa Bioscience Inc. / Minaris Advanced Therapies / TOKIWA-BIO INC. / Human Life CORD, Inc. / CM-Plus Corporation / SEKISUI CHEMICAL CO., LTD. |
| 17:00-18:00 | Attendee Networking |
Speakers
[Participating Companies and Organizations] *Subject to change*
1. Japan:
Forum for Innovative Regenerative Medicine (FIRM)
DCI Partners Co., Ltd.
LINK-J
[Companies presenting at the pitch section]
SyntheticGestalt K.K. / DiveRadGel Co., Ltd. / Auxilart Co., Ltd. / Amelieff Coporation /
FonesLife Coporation / Cellafa Bioscience Inc. / Minaris Advanced Therapies /
TOKIWA-BIO INC. / Human Life CORD, Inc. / CM-Plus Corporation / SEKISUI CHEMICAL CO., LTD.
2. Taiwan:
Development Center for Biotechnology, DCB
Biotechnology and Pharmaceutical Industries Promotion Office, BPIPO
Taiwan Association for Cellular Therapy, TACT
[Companies presenting at the pitch section]
Hualien Tzu Chi Hospital / HERON NEUTRON MEDICAL CORP. /
AngenMed Therapeutics, Inc. / STEMCELL BioTech CO., LTD. / HeXun Biosciences Co., Ltd. /
TIMING PHARMACEUTICAL CO., LTD. / Taiwan Exosome CO., LTD. / Spirit Scientific Co., Ltd /
Steminent Biotherapeutics Inc.
Notice Regarding the Handling of Personal Information
The personal information that you have filled out and submitted will be handled by LINK-J in accordance with the following policy. Photos and videos taken at this event may be used by LINK-J and other related parties on websites, pamphlets, etc.
<<Personal Information Protection Policy>> https://www.link-j.org/en/privacy/
<<Concerning Protection of Personal Information>> https://www.link-j.org/en/use/
Participation Fee
Participation Free
Capacity
150 persons
Organizer
Organized by Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO)
Co-organized by Link-J, Development Center for Biotechnology (DCB)
Collaborated by Forum for Innovative Regenerative Medicine (FIRM)
Contact
If you have any questions about this form, please contact to BPIPO:
Cindy: slc@biopharm.org.tw
Lynn: lynn@biopharm.org.tw
